TY - JOUR
T1 - Protein kinase cδ differentially regulates platelet functional responses
AU - Chari, Ramya
AU - Getz, Todd
AU - Nagy, Bela
AU - Bhavaraju, Kamala
AU - Mao, Yingying
AU - Bynagari, Yamini Saraswathy
AU - Murugappan, Swaminathan
AU - Nakayama, Keiko
AU - Kunapuli, Satya P.
PY - 2009/5
Y1 - 2009/5
N2 - OBJECTIVE-: Protein Kinase C delta (PKCδ) is expressed in platelets and activated downstream of protease-activated receptors (PAR)s and glycoprotein VI (GPVI) receptors. The purpose of this study was to investigate the role of PKCδ in platelets. METHODS AND RESULTS-: We evaluated the role of PKCδ in platelets using two approaches-pharmacological and molecular genetic approach. In human platelets pretreated with isoform selective antagonistic RACK peptide (δ V1-1)TAT, and in the murine platelets lacking PKCδ, PAR4-mediated dense granule secretion was inhibited, whereas GPVI-mediated dense granule secretion was potentiated. These effects were statistically significant in the absence and presence of thromboxane A2 (TXA2). Furthermore, TXA2 generation was differentially regulated by PKCδ. However, PKCδ had a small effect on platelet P-selectin expression. Calcium- and PKC-dependent pathways independently activate fibrinogen receptor in platelets. When calcium pathways are blocked by dimethyl-BAPTA, AYPGKF-induced aggregation in PKCδ null mouse platelets and in human platelets pretreated with (δ V1-1)TAT, was inhibited. In a FeCl3-induced injury in vivo thrombosis model, PKCδ mice occluded similar to their wild-type littermates. CONCLUSIONS-: Hence, we conclude that PKCδ differentially regulates platelet functional responses such as dense granule secretion and TXA2 generation downstream of PARs and GPVI receptors, but PKCδ deficiency does not affect the thrombus formation in vivo.
AB - OBJECTIVE-: Protein Kinase C delta (PKCδ) is expressed in platelets and activated downstream of protease-activated receptors (PAR)s and glycoprotein VI (GPVI) receptors. The purpose of this study was to investigate the role of PKCδ in platelets. METHODS AND RESULTS-: We evaluated the role of PKCδ in platelets using two approaches-pharmacological and molecular genetic approach. In human platelets pretreated with isoform selective antagonistic RACK peptide (δ V1-1)TAT, and in the murine platelets lacking PKCδ, PAR4-mediated dense granule secretion was inhibited, whereas GPVI-mediated dense granule secretion was potentiated. These effects were statistically significant in the absence and presence of thromboxane A2 (TXA2). Furthermore, TXA2 generation was differentially regulated by PKCδ. However, PKCδ had a small effect on platelet P-selectin expression. Calcium- and PKC-dependent pathways independently activate fibrinogen receptor in platelets. When calcium pathways are blocked by dimethyl-BAPTA, AYPGKF-induced aggregation in PKCδ null mouse platelets and in human platelets pretreated with (δ V1-1)TAT, was inhibited. In a FeCl3-induced injury in vivo thrombosis model, PKCδ mice occluded similar to their wild-type littermates. CONCLUSIONS-: Hence, we conclude that PKCδ differentially regulates platelet functional responses such as dense granule secretion and TXA2 generation downstream of PARs and GPVI receptors, but PKCδ deficiency does not affect the thrombus formation in vivo.
KW - Fibrinogen
KW - Platelets
KW - Protein kinase C
KW - Secretion
KW - Thrombosis
UR - http://www.scopus.com/inward/record.url?scp=65549123690&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=65549123690&partnerID=8YFLogxK
U2 - 10.1161/ATVBAHA.109.184010
DO - 10.1161/ATVBAHA.109.184010
M3 - Article
C2 - 19213940
AN - SCOPUS:65549123690
VL - 29
SP - 699
EP - 705
JO - Arteriosclerosis, Thrombosis, and Vascular Biology
JF - Arteriosclerosis, Thrombosis, and Vascular Biology
SN - 1079-5642
IS - 5
ER -